MON -

NYSE American . Currency in USD
Stock chart is not supported by your current browser
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Range0.09 - 0.09
VolumeN/A
Avg. Volume0
Market CapN/A
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Congress preparing a key bill for cannabis that could be ...
    CNBC Videos4 months ago

    Congress preparing a key bill for cannabis that could be ...

    Will pot get a political boost from Congress? With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Brian Kelly, Steve Grasso and Guy Adami.

  • Jury: Roundup weed killer is major factor in man's cancer
    Associated Press5 days ago

    Jury: Roundup weed killer is major factor in man's cancer

    SAN FRANCISCO (AP) — Roundup weed killer was a substantial factor in a California man's cancer, a jury determined Tuesday in the first phase of a trial that attorneys said could help determine the fate of hundreds of similar lawsuits.

  • Reuters13 days ago

    In fresh blow to Monsanto, India cuts GM cotton seed royalty

    India has cut the royalties that local seed companies pay to German drugmaker Bayer AG's Monsanto unit for the third time in four years. Prime Minister Narendra Modi's government has decided to reduce royalties paid by Indian seed companies to Monsanto for its genetically modified (GM) cotton by 49 percent to 20 rupees for a packet of 450 grams, according to a farm ministry order. The decision could prompt Monsanto and other foreign seed companies to further scale back investment in the sector, said Ram Kaundinya, director general of the Federation of Seed Industry of India.

  • High-stakes trial starts in Roundup weed killer cancer claim
    Associated Press26 days ago

    High-stakes trial starts in Roundup weed killer cancer claim

    SAN FRANCISCO (AP) — A jury in federal court in San Francisco will decide whether Roundup weed killer caused a California man's cancer in a trial starting Monday that plaintiffs' attorneys say could help determine the fate of hundreds of similar lawsuits.

  • Moody'slast month

    Monsanto Finance Canada Co. -- Moody's withdraws Monsanto Company ratings

    Rating Action: Moody's withdraws Monsanto Company ratings. Global Credit Research- 12 Feb 2019. Approximately $1.0 billion of rated debt affected.

  • Reuterslast month

    Exclusive: Monsanto wins arbitration ruling over royalties from Indian seed company

    German drugmaker Bayer AG's Monsanto unit has won proceedings against Indian seed maker Nuziveedu Seeds Ltd (NSL) in a royalty dispute, lawyers familiar with the matter said. The lawyers, who did not wish to be named as the decision was not public, did not disclose the terms of the arbitration ruling. Mahyco Monsanto Biotech (India) (MMB), a joint venture between Missouri-based Monsanto and India's Maharashtra Hybrid Seeds Co (Mahyco), "has received a favourable award from the arbitration panel in the proceedings against NSL and Prabhat", a Bayer spokesman said in an e-mailed statement when asked about the ruling.

  • Reuters2 months ago

    Return of French farmer's case keeps Monsanto in legal spotlight

    A decade-old lawsuit in which a French farmer with neurological problems accuses Monsanto of not providing adequate safety warnings for a weedkiller returns to court on Wednesday, adding to health claims faced by the Bayer-owned firm. Paul Francois, who says he fell ill after inhaling vapour from weedkiller Lasso in 2004, won rulings in 2012 and 2015 that found Monsanto liable for the intoxication, before France's top court overturned those decisions and ordered a new hearing. An appeal court in the southeastern French city of Lyon will hear arguments on Wednesday before giving its verdict at a later date.

  • Monsanto patent victory seen as a boost for biotech investment in India
    Reuters2 months ago

    Monsanto patent victory seen as a boost for biotech investment in India

    NEW DELHI/MUMBAI (Reuters) - India's Supreme Court ruled on Tuesday that Monsanto can claim patents on its genetically modified (GM) cotton seeds, a victory for the U.S. company that is expected to encourage biotechnology firms to step up investment in the country. The decision on appeal overturns an earlier ruling by the Delhi High Court that Monsanto - the world's biggest seed maker, which has been bought by Germany's Bayer AG - could not claim patents on GM cotton seeds.

  • Swadeshi Jagran Manch seeks change in patent act after pro-Monsanto court verdict
    Reuters2 months ago

    Swadeshi Jagran Manch seeks change in patent act after pro-Monsanto court verdict

    A nationalist group close to Indian Prime Minister Narendra Modi's party said on Tuesday it would seek a legislative amendment to the rules governing patents, after the country's top court ruled in favour of Monsanto's cotton seed patent. The Supreme Court allowed Monsanto to claim patents on its genetically modified cotton seeds in the world's biggest producer of the fibre, overturning a decision of a lower court.

  • Business Wire3 months ago

    SolomonEdwards D.C. Practice Expands With New Experts

    SolomonEdwards, a national professional services firm, has added Kimberly Rodichok to its consulting team as a Director in their Technical Accounting and Regulatory Advisory Services Practice. As Director, Kimberly joins Brian McAuliffe, both of whom will support Greater Washington D.C. metro businesses in the areas of business transformation and project management. Kimberly, a seasoned management consultant with an accomplished history of providing counsel to federal clients, has a proven track record of effectively overseeing teams and elaborate projects.

  • Judge upholds Monsanto weed killer cancer verdict but slashes damages to groundsman
    The Telegraph5 months ago

    Judge upholds Monsanto weed killer cancer verdict but slashes damages to groundsman

    A San Francisco judge on Monday upheld a jury verdict that found Monsanto liable for not warning a groundskeeper that its weed killer Roundup might cause cancer, but slashed the damages award.

  • Brazil court denies Monsanto bid to halt seed licensing to bankrupt firm
    Reuters5 months ago

    Brazil court denies Monsanto bid to halt seed licensing to bankrupt firm

    A Brazilian appeals court denied a request this month by Monsanto's local unit to suspend licensing of its popular Intacta soy seed technology to privately owned seed maker Sementes Talismã, according to a ruling seen by Reuters. Monsanto sought to suspend the licensing of the genetically modified seed technology after Talismã filed for bankruptcy protection in January, one of the seed maker's lawyers, Daniel Amaral of DASA Advogados in São Paulo, said. "Monsanto sought to end the licensing contract to try and negotiate better terms in Talismã's ongoing financial restructuring," Amaral said.

  • Jurors: Don't throw out $289M weed killer cancer verdict
    Associated Press5 months ago

    Jurors: Don't throw out $289M weed killer cancer verdict

    SAN FRANCISCO (AP) — Jurors who found that agribusiness giant Monsanto's Roundup weed killer contributed to a school groundskeeper's cancer are urging a San Francisco judge not to throw out the bulk of their $289 million award in his favor, a newspaper reported Monday.

  • Global executives cooling on deals amid trade uncertainty
    Associated Press5 months ago

    Global executives cooling on deals amid trade uncertainty

    LONDON (AP) — Executives around the world are cooling to the idea of mergers and acquisitions in the face of rising trade tensions, notably between the U.S. and China, a leading adviser on international corporate deals said Monday.

  • Bayer's Monsanto asks U.S. court to toss $289 mln glyphosate verdict
    Reuters6 months ago

    Bayer's Monsanto asks U.S. court to toss $289 mln glyphosate verdict

    The company said in motions filed in San Francisco's Superior Court of California that the jury's decision was insufficiently supported by the evidence presented at trial by school groundskeeper Dewayne Johnson. Johnson's case, filed in 2016, was fast-tracked for trial due to the severity of his non-Hodgkin's lymphoma, a cancer of the lymph system, that he alleged was caused by years of exposure to Roundup and Ranger Pro, another Monsanto herbicide that contains glyphosate. Monsanto asked Superior Court Judge Suzanne Bolanos, who oversaw the trial, to set aside the verdict or, in the alternative, reduce the award or grant a new trial.

  • Reuters7 months ago

    Bayer cuts forecasts on Monsanto delay as lawsuits pile up

    Bayer cut its earnings forecast on Wednesday due to delays to its $63 billion takeover of Monsanto, and said sales of its consumer care products fell, hitting its shares, already reeling from a legal battle over the weed killer Roundup. The weaker earnings forecast adds to a number of challenges facing the German drugmaker as it braces for years of legal wrangling over the alleged cancer risks of glyphosate-based weedkillers. Bayer said the number of plaintiffs seeking damages over Monsanto's Roundup and Ranger Pro herbicides had risen to 8,700 from 8,000 from last month, and said that it expected more to sue.

  • Reuters7 months ago

    EPA should revoke Monsanto weed killer approval, groups tell U.S. court

    The groups, which filed a lawsuit in February, want the court to force the EPA to vacate its approval of XtendiMax, arguing it not only harms nearby crops and plants but wildlife as well. It is not clear whether the court has the authority to revoke an EPA approval. The United States has faced a weed-killer crisis caused by the new formulations of dicamba-based herbicides, which farmers and weed experts say have harmed crops because they evaporate and drift away from where they are applied.

  • Reuters7 months ago

    Bayer says can begin integration of Monsanto

    Bayer can begin folding Monsanto into its organisation as the antitrust-related sale of assets has been completed, fulfilling final requirements by the U.S. Department of Justice, the German drugmaker said on Thursday. "The integration of Monsanto into the Bayer Group can begin following the completion on Thursday of the divestment by Bayer to BASF of certain Crop Science businesses with a total sales volume of around 2.2 billion euros," it said in a statement. Bayer already closed the deal, becoming the sole owner of Monsanto, on June 7 but had to hold off on the integration.

  • Reuters7 months ago

    Exclusive: U.S. seed sellers push for limits on Monsanto, BASF weed killer

    America's two biggest independent seed sellers, Beck's Hybrids and Stine Seed, told Reuters they are pushing U.S. environmental regulators to bar farmers from spraying dicamba weed killer during upcoming summers in a potential blow to Bayer AG's Monsanto Co. Limiting spraying of the chemical to the spring season, before crops are planted, would prevent farmers from using the herbicide on dicamba-resistant soybeans that Monsanto engineered. The seeds are sold by companies including Beck's and Stine.

  • Reuters7 months ago

    Analysis: Monsanto Roundup appeal has uphill climb on 'junk science' grounds - legal experts

    Bayer AG unit Monsanto faces long odds on an appeal blaming an "inflamed" jury and "junk science" for a verdict of $289 million in damages to a man who said the company's Roundup weed killer caused his cancer, according to some legal experts. Last week's verdict ended the first trial over whether glyphosate, the main ingredient in Roundup, causes cancer. Monsanto, which says decades of scientific studies have shown Roundup and glyphosate are safe, is facing about 5,000 similar lawsuits nationwide.

  • Monsanto Roundup appeal has uphill climb on 'junk science' grounds: legal experts
    Reuters7 months ago

    Monsanto Roundup appeal has uphill climb on 'junk science' grounds: legal experts

    Last week's verdict ended the first trial over whether glyphosate, the main ingredient in Roundup, causes cancer. Monsanto, which says decades of scientific studies have shown Roundup and glyphosate are safe, is facing about 5,000 similar lawsuits nationwide. Monsanto said on Monday it planned to challenge the verdict on the grounds that the judge should have barred scientific evidence presented by California school groundskeeper Dewayne Johnson's lawyers as insufficient.

  • Roundup cancer verdict sends Bayer shares sliding
    Reuters7 months ago

    Roundup cancer verdict sends Bayer shares sliding

    Bayer (BAYGn.DE) shares plunged as much as 14 percent on Monday, losing about $14 billion (£10.95 billion) in value, after newly acquired Monsanto was ordered to pay $289 million in damages in the first of possibly thousands of U.S. lawsuits over alleged links between a weedkiller and cancer. After the verdict in favour of a California school groundskeeper with terminal cancer, Monsanto faces more than 5,000 similar lawsuits across the United States over claims it did not warn of the cancer risks of glyphosate-based weedkillers, including its Roundup brand. Monsanto, bought by Bayer this year for $63 billion, said that it would appeal against the jury's verdict in California, which is the latest episode in a long-running debate over claims that exposure to Roundup can cause cancer.

  • Monsanto ordered to pay $289m to terminally ill groundsman who used Roundup weedkiller
    The Telegraph7 months ago

    Monsanto ordered to pay $289m to terminally ill groundsman who used Roundup weedkiller

    Monsanto ordered to pay $289m to terminally ill groundsman who used Roundup weedkiller